Reference
Kaluzna-Oleksy M, et al. Initial clinical experience with the first drug (sacubitril/valsartan) in a new class - Angiotensin receptor neprilysin inhibitors in patients with heart failure with reduced left ventricular ejection fraction in Poland. Kardiologia Polska 76: 381-387, No. 2, 16 Feb 2018. Available from: URL: http://doi.org/10.5603/KP.a2017.0230 - Poland
Rights and permissions
About this article
Cite this article
Sacubitril/valsartan. Reactions Weekly 1695, 331 (2018). https://doi.org/10.1007/s40278-018-44158-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44158-x